Lockheed Invests in DarwinAI to Advance COVID-19 Diagnosis Initiative
Lockheed Martin has invested $750K in Canada-based artificial intelligence company DarwinAI to help the latter operationalize a project that seeks to accelerate diagnosis of COVID-19 through chest X-ray scans. Lockheed made the investment in DarwinAI through its Canadian arm and as part of the Industrial Technological Benefits policy.